Acquisition

MPS Ltd., via its US subsidiary, has acquired 100% of Unbound Medicine, Inc. for USD 16.50 Million (~137 Cr). Unbound Medicine is a US-based healthcare learning technology firm offering mobile-first, AI-powered clinical decision support platforms, boasting a ~97% recurring revenue model.

This acquisition marks MPS's strategic entry into the high-growth healthcare IT sector, complementing its digital publishing and learning solutions.

It expands MPS's platform offerings, unlocks cross-selling opportunities to institutional clients like medical schools, and accelerates AI-driven innovation through MPS Labs, positioning MPS for resilient, platform-led growth.